Fonar ROE 2006-2019 | FONR

Current and historical return on equity (ROE) values for Fonar (FONR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Fonar ROE for the three months ending March 31, 2019 was 17.82%.
Fonar ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.02B $0.11B 17.55%
2018-12-31 $0.02B $0.11B 17.48%
2018-09-30 $0.02B $0.11B 19.39%
2018-06-30 $0.02B $0.10B 20.49%
2018-03-31 $0.02B $0.09B 18.18%
2017-12-31 $0.02B $0.09B 22.75%
2017-09-30 $0.02B $0.09B 24.28%
2017-06-30 $0.02B $0.08B 25.94%
2017-03-31 $0.02B $0.08B 28.04%
2016-12-31 $0.02B $0.07B 25.20%
2016-09-30 $0.02B $0.07B 24.90%
2016-06-30 $0.02B $0.06B 26.32%
2016-03-31 $0.01B $0.06B 25.69%
2015-12-31 $0.01B $0.06B 25.12%
2015-09-30 $0.01B $0.05B 23.88%
2015-06-30 $0.01B $0.05B 22.45%
2015-03-31 $0.01B $0.05B 20.94%
2014-12-31 $0.01B $0.05B 21.39%
2014-09-30 $0.01B $0.05B 22.35%
2014-06-30 $0.01B $0.05B 23.39%
2014-03-31 $0.01B $0.04B 24.54%
2013-12-31 $0.01B $0.04B 23.23%
2013-09-30 $0.01B $0.04B 25.20%
2013-06-30 $0.01B $0.04B 28.00%
2013-03-31 $0.00B $0.04B 21.92%
2012-12-31 $0.00B $0.01B 32.65%
2012-09-30 $0.00B $0.01B 36.36%
2012-06-30 $0.00B $0.01B 42.11%
2012-03-31 $0.00B $0.01B 36.36%
2011-12-31 $0.00B $0.01B 57.14%
2011-09-30 $0.00B $0.01B 150.00%
2011-06-30 $0.00B $0.01B -200.00%
2011-03-31 $0.00B $-0.00B -50.00%
2010-12-31 $0.00B $-0.00B -19.05%
2010-09-30 $-0.00B $-0.01B 17.39%
2010-06-30 $-0.00B $-0.01B 52.17%
2010-03-31 $-0.00B $-0.01B 60.00%
2009-12-31 $-0.00B $-0.01B 47.06%
2009-09-30 $0.00B $-0.01B 0.00%
2009-06-30 $0.00B $-0.00B -53.33%
2009-03-31 $-0.01B $-0.00B 125.00%
2008-12-31 $-0.01B $-0.00B 360.00%
2008-09-30 $-0.01B $-0.01B 5600.00%
2008-06-30 $-0.01B $-0.00B -430.77%
2008-03-31 $-0.02B $0.00B -246.15%
2007-12-31 $-0.02B $0.01B -180.00%
2007-09-30 $-0.02B $0.01B -131.03%
2007-06-30 $-0.03B $0.01B -129.87%
2007-03-31 $-0.03B $0.02B -102.04%
2006-12-31 $-0.03B $0.02B -90.76%
2006-09-30 $-0.03B $0.03B -77.14%
2006-06-30 $-0.03B $0.03B -72.96%
2006-03-31 $-0.02B $0.04B -44.20%
2005-12-31 $-0.01B $0.04B -26.67%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.139B $0.082B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.856B 28.70
Medtronic (MDT) Ireland $133.874B 19.12
Stryker (SYK) United States $76.669B 27.36
Boston Scientific (BSX) United States $59.033B 28.30
Baxter (BAX) United States $41.839B 26.37
EssilorLuxottica Societe Anonyme (ESLOY) France $29.060B 0.00
Coloplast (CLPBY) Denmark $25.618B 40.90
Zimmer Biomet Holdings (ZBH) United States $24.965B 16.04
Lonza Group Ag (LZAGY) Switzerland $24.947B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.274B 0.00
ResMed (RMD) United States $17.745B 33.90
Canopy Growth (CGC) Canada $12.161B 0.00
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Bio-Rad Laboratories (BIO) United States $9.308B 49.34
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.203B 524.78
Aurora Cannabis (ACB) Canada $7.109B 70.10
Perrigo (PRGO) Ireland $7.004B 11.84
Hill-Rom Holdings (HRC) United States $6.993B 21.20
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.325B 51.63
ICU Medical (ICUI) United States $5.135B 30.64
GW Pharmaceuticals (GWPH) United Kingdom $5.057B 0.00
Neogen (NEOG) United States $3.349B 54.45
NuVasive (NUVA) United States $2.982B 24.36
Hutchison China MediTech (HCM) China $2.925B 0.00
Agios Pharmaceuticals (AGIO) United States $2.711B 0.00
National Vision Holdings (EYE) United States $2.420B 51.57
Quidel (QDEL) United States $2.309B 23.96
Cardiovascular Systems (CSII) United States $1.598B 917.80
Aphria (APHA) $1.579B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.41
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.187B 25.19
Lantheus Holdings (LNTH) United States $1.089B 28.93
NanoString Technologies (NSTG) United States $1.056B 0.00
PetIQ (PETQ) United States $0.994B 24.14
MacroGenics (MGNX) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.765B 21.47
Cerus (CERS) United States $0.758B 0.00
Quanterix (QTRX) United States $0.753B 0.00
Omeros (OMER) United States $0.750B 0.00
TG Therapeutics (TGTX) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.572B 27.71
Surmodics (SRDX) United States $0.543B 78.88
OraSure Technologies (OSUR) United States $0.531B 24.43
Meridian Bioscience (VIVO) United States $0.476B 14.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.404B 0.00
Vapotherm (VAPO) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.13
BioLife Solutions (BLFS) United States $0.304B 95.24
Zynex (ZYXI) United States $0.250B 25.67
Bovie Medical (APYX) United States $0.236B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.198B 4.20
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Female Health (VERU) United States $0.146B 0.00
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.094B 20.65
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00